This observation mirrors what has recently been reported for breast cancer, as it was suggested that the Her2+ and the triple negative subtypes of breast cancer are associated with increased expression of KMO and KNYU and utilization of those branches of the KP versus patients with luminal breast cancer [29]. The gene discussed is KMO; the disease is breast carcinoma.